Non-Hodgkin Lymphomas

  1. The superficial cortex is predominantly a ____-cell zone; the deep cortex is more of a ____- cell zone. ________ cells are more prominent in the medulla.
    • B
    • T
    • Plasma
  2. What is the presence of enlarged lymph nodes referred to as?
    Lymphadenopathy
  3. Non-Hodgkin Lymphomas are neoplastic, clonal proliferations of lymphocytes. These may be nodal, extranodal, or both. Which is more common?
    They may also be B-cell or T-cell derived. Which is more common in the US?
    • Nodal
    • B-cell
  4. Do Non-Hodgkin Lymphomas tend to be disseminated (systemic) or localized at diagnosis?
    Disseminated
  5. Lymphomas are tumors of what?
    Lymphocytes
  6. Non-Hodgkin Lymphomas tend to be diseases predominantly of what age group?
    Older -- 60s and 70s
  7. Most cases of Non-Hodgkin Lymphomas have no obvious predisposing factor, but what are some possible predisposing factors?
    • Genetic Predispostion
    • Chemical Exposure
    • Ionizing Radiation
    • Immunosuppression
    • Viral Infections
    • Chronic Antigenic Stimulation
    • Autoimmune Diseases
  8. The immunoglobulin heavy chain gene (IgH) is located on the long arm of chromosome ____; this locus is probably the single most common locus involved in chromosome translocations in B-cell Non-Hodgkin Lymphomas.
    14 (14q)
  9. In Non-Hodgkin Lymphomas, recurrent cytogenetic alterations are common. These are usually _________ translocations. There are specific alterations associated with specific lymphoma types, and these usually involve ______________ and either ____________ genes (B-cells) or _______________ genes (T-cells).
    • Reciprocal
    • Proto-Oncogenes
    • Immunoglobulin Genes
    • T-cell Receptor Genes
  10. Lymphocytes are the only cells in the body where -- as a part of normal development -- the DNA gets cut up and stitched back together. This occurs in the immunoglobulin (Ig) genes in B-cells and the T-cell receptor (TCR) genes in T-cells. Rearrangement may occur between these two genes and what? What does this predispose to?
    • Proto-oncogenes
    • Genetic Accidents
  11. What are the cytogenetics associated with Burkitt Lymphomas? __________ is associated with cell proliferation; it is overexpressed in Burkitt Lymphomas.
    • t(8;14)
    • c-MYC/Immunoglobulin Heavy Chain Gene (IgH)
  12. What are the cytogenetics associated with Follicular Lymphomas? The ________ protein confers resistance to apoptosis; follicular lymphomas don't grow because the cells proliferate quickly, but grow slowly; the cells just don't die.
    • t(14;18)
    • IgH/BCL-2
  13. What are the cytogenetics associated with Mantle Cell Lymphoma? The _________ protein is associated with cell proliferation, but it doesn't drivge rapid proliferation; just slower but relentless.
    • t(11;14)
    • Cyclin D1/IgH
  14. What is the most common clinical presentation of Non-Hodgkin Lymphoma? What are some other symptoms?
    • Enlarged Lymph Nodes: most common
    • Tumor in Extranodal Sites -- GI tract, skin, brain, other organs
    • Systemic Symptoms -- fever, night sweats, weight loss
    • Hematologic Disease -- lymphocytosis, leukopenia, anemia, thrombocytopenia
  15. What does the WHO classification system attempt to do?
    Identify distinct entities, based when possible on cell of origin
  16. What is an important difference between the WHO classification system and the Working Formualtion (older classification system)?
    The WHO does not divide NHL into broad prognostic groups
  17. What are the three main categories of the WHO Classification System? What types of tumors does this include?
    • B-cell (including plasma cell)
    • T-cell
    • Hodgkin Lymphomas
    • Includes all tumors derived from lymphocytes: both lymphocytic lymphomas and lymphocytic leukemias
  18. Under the WHO Classification System, B-cell and T-cell neoplasms are divided into what two types?
    • Immature (precursors): acute lymphoblastic leukemias and lymphoblastic lymphomas
    • Mature (peripheral): most NHL, chronic lymphocytic leukemias, plasma cell neoplasms
  19. What is the difference between lymphomas and leukemias?
    • Lymphoma: no bone marrow involvement
    • Leukemia: bone marrow involvement
  20. In general, __________ architecture and _______ cell size indicate more aggressive clinical behavior.
    • Diffuse
    • Large
  21. What are the two architectural types involved in Non-Hodgkin Lymphomas? Which is linked to more aggressive behavior?
    • Follicular & Diffuse
    • Diffuse
  22. When looking at NHL types by histological grade, which type makes up about half of lymphomas? Which type constitutes about a quarter? And which type is rare?
    • Intermediate Grade Lymphomas
    • Low Grade Lymphomas
    • True High Grade Lymphomas
  23. What is the single most common type of non-Hodgkin lymphoma in the US?
    Diffuse Large B-Cell Lymphomas (DLBCL)
  24. Are Diffuse Large B-Cell Lymphomas typically indolent or aggressive? A significant number of patients are curable with with treatment?
    • Aggressive
    • Combination Chemotherapy
  25. What are the two major molecular subtypes of Diffuse Large B-Cell Lymphomas (DLBCLs)? What is the prognosis with each?
    • Germinal Center B-Cell: better prognosis
    • Activated (non-germinal center) B-Cell: more aggressive; worse prognosis
  26. Identify the lymphoma type seen below:
    Image Upload 2
    Diffuse Large B-Cell Lymphoma (DLBCL)
  27. What is the second most common Non-Hodgkin Lymphoma in the US?
    Follicular Lymphoma
  28. Are Follicular Lymphomas typically indolent or aggressive?
    Indolent
  29. Most Follicular Lymphomas aren't rapidly proliferative. Why/how do they grow?
    Because the cells aren't dying like they should due to the anti-apoptotic gene (BCL2)
  30. Follicular lymphomas are divided into three grades. What are the grades based on? Which is more aggressive, grade 1 or grade 3?
    • Based on the number of large cells in the neoplastic follicles (grade 1 has fewest, grade 3 the most)
    • Grade 3
  31. What is the most common extranodal lymphoma in the US? Where are most of these located? Are they typically indolent or aggressive?
    • Extranodal Marginal Zone (MALT) Lymphomas
    • GI Tract
    • Indolent
  32. Unlike other low-grade lymphomas, what type tend to be localized on diagnosis and are potentially curable if they are localized?
    Extranodal Marginal Zone (MALT) Lymphomas
  33. Which type of lymphoma responds to antibiotics and often doesn't require chemo?
    Gastric MALT Lymphomas
  34. Gastric MALT Lymphomas are often associated with what type of bacteria, and may even regress after eradication of this bacteria?
    H. pylori
  35. Small Lymphoctyic Lymphoma (SLL) is essentially identical to B-cell chronic lymphocytic leukemia (B-CLL). What distinguishes the two?
    Presence or absence of lymphocytosis
  36. Identify the Lymphoma below:
    Image Upload 4
    Small Lymphocytic Lymphoma
  37. What is possibly the worst of all lymphomas? This type has a relatively short survival (median 3-5 years), and is incurable with conventional therapy.
    Mantle Cell Lymphoma
  38. What lymphoma has the fastest doubling time of any neoplasm? This is a very high grade NHL. It is strongly associated with EBV and has malaria as a co-factor (therefore is common in Africa).
    Burkitt Lymphoma
  39. Identify the lymphoma type below:
    Image Upload 6
    • Burkitt Lymphoma
    • "Starry Sky" Pattern
  40. What type of lymphomas are highly heterogenous in all respects, tend to be aggressive clinically (often advanced stage, systemic symptoms common, extranodal disease frequent), and has a bad overall prognosis? There are several variants of these.
    T-Cell Lymphomas
  41. What is the most common T-cell Lymphoma? What is very important at diagnosis for T-cell lymphomas?
    • Peripheral T-cell lymphoma, unspecified (PTCL)
    • Clinical presentation -- sites of involvement, presence of systemic symptoms
  42. What does the Ann Arbor Staging System Measure?
    Anatomic spread of disease
  43. What drug, known as an anti-CD20 antibody (CD20 = B-cell antigen), is often used in combination with chemo to treat Non-Hodgkin Lymphomas? This drug is also commonly used in low grade B-cell lymphomas.
    Rituxan (Rituximab)
  44. What is the common treatment for Aggressive NHLs?
    Combination of chemo used (CHOP plus Rituximab)
  45. In NHL, serum LDH tends to correlate with tumor bulk and aggressiveness: the bulkier and/or more aggressive the disease, the ___________ the LDH is going to be. However, this is not specific for lymphomas.
    Higher
  46. There is a marked increase in NHL risk in what patient subset? These are nearly always aggressive or high-grade types. B-cell >> T-cell. Incidence increases with decreasing _____ count.
    • HIV-positive patients
    • CD4
  47. What type of lymphoma is relatively common in HIV patients, but is very rare in non-immunocompromised patients?
    Primary CNS Lymphoma (lymphoma involving the CNS with no evidence of lymphoma elsewhere)
  48. What is another disorder, very similar to HIV-related lymphomas, that is liekly due to these patients being in an immunocompromised state? These are often high stage, extranodal sites; have aggressive histologic types, B-cell >> T-cell; EBV involved in pathogenesis (all similar to HIV-related).
    Post-Transplant Lymphoproliferative Disorders (PTLD)
  49. What is the most common cause of reactive lymphadenopathy (common in children, less so in adults) (part of differential for enlarged lymph nodes)?
    Infections
  50. What are the two main options for pathologic diagnosis of Lymphoma?
    • Fine Needle Aspirate Cytology (FNA)
    • Excisional Biopsy
  51. Fine Needle Aspirate Cytology can often be used to make a definitive diagnosis of NHL when combined with what other test?
    Flow Cytometry
  52. What group of lymphomas have a long median survival, but are incurable with conventional therapy?
    Indolent
  53. What group of lymphomas are potentially curable with chemotherapy, but have a shorter survival if not cured?
    Aggressive
Author
julieaburch
ID
86419
Card Set
Non-Hodgkin Lymphomas
Description
Non-Hodgkin Lymphomas
Updated